For Detecting 2019-nCoV was Listed in the Emergency Use Listing of WHO May 10, 2020, BGI Europe A/S, a subsidiary of BGI Genomics today announced that its Real-time fluorescent RT-PCR...Read More
to Supply SARS-CoV-2 RT-PCR Test in Canadian Market BGI Genomics announced today that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its...Read More
to Enable COVID-19 Testing for 30% of the Population in the Next 8 Months SHENZHEN, China, April 27, 2020: BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia’s National Unified Procurement...Read More
